The incidence of active TB in individuals who were treated using anti-TNF-α therapy was previously reported in a meta-analysis involving 11,879 people, identifying an incidence rate 1.94 (1.10–3.44) times higher in these individuals [19]. The gene discussed is TNF; the disease is tuberculosis.